|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0038257,
umls-concept:C0087111,
umls-concept:C0205042,
umls-concept:C0205210,
umls-concept:C0221198,
umls-concept:C0302891,
umls-concept:C1456025,
umls-concept:C1515568,
umls-concept:C1522577,
umls-concept:C1705899
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-12-24
|
|
pubmed:abstractText |
This article reports the 2-year clinical, angiographic, and intravascular ultrasound outcomes of the everolimus-eluting stent (EES) compared with the paclitaxel-eluting stent (PES) in the randomized SPIRIT II trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1941-7632
|
|
pubmed:author |
pubmed-author:BeijkMarcel AMA,
pubmed-author:ClaessenBimmer EBE,
pubmed-author:HenriquesJose P SJP,
pubmed-author:LegrandVictorV,
pubmed-author:ManariAntonioA,
pubmed-author:Miquel-HebertKarineK,
pubmed-author:PiekJan JJJ,
pubmed-author:RuzylloWitoldW,
pubmed-author:SerruysPatrick WPW,
pubmed-author:SuttorpMaarten JMJ,
pubmed-author:TijssenJan G PJG,
pubmed-author:VarenneOlivierO,
pubmed-author:VeldhofSusanS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
339-47
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20031737-Aged,
pubmed-meshheading:20031737-Angioplasty, Balloon, Coronary,
pubmed-meshheading:20031737-Cardiovascular Agents,
pubmed-meshheading:20031737-Coronary Angiography,
pubmed-meshheading:20031737-Coronary Artery Disease,
pubmed-meshheading:20031737-Drug-Eluting Stents,
pubmed-meshheading:20031737-Europe,
pubmed-meshheading:20031737-Female,
pubmed-meshheading:20031737-Humans,
pubmed-meshheading:20031737-India,
pubmed-meshheading:20031737-Kaplan-Meier Estimate,
pubmed-meshheading:20031737-Male,
pubmed-meshheading:20031737-Middle Aged,
pubmed-meshheading:20031737-Myocardial Infarction,
pubmed-meshheading:20031737-Myocardial Ischemia,
pubmed-meshheading:20031737-New Zealand,
pubmed-meshheading:20031737-Paclitaxel,
pubmed-meshheading:20031737-Prospective Studies,
pubmed-meshheading:20031737-Single-Blind Method,
pubmed-meshheading:20031737-Sirolimus,
pubmed-meshheading:20031737-Thrombosis,
pubmed-meshheading:20031737-Time Factors,
pubmed-meshheading:20031737-Treatment Outcome,
pubmed-meshheading:20031737-Ultrasonography, Interventional
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.
|
|
pubmed:affiliation |
Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands. B.E.Claessen@amc.uva.nl
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
